FDA Inspection 1320016 — Jo-Anne H. Young, MD, FACP
The FDA completed an inspection of Jo-Anne H. Young, MD, FACP on May 21, 2026 in Minneapolis, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 21, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Minneapolis, MN (United States)
Additional Details
Clinical Investigator (CI)